News

January 19, 2018December 18, 2019

Intratumoral Therapy Increases Response to Checkpoint Inhibitor in Triple Negative Breast Cancer, Study Finds

News

Combining OncoSec Medical‘s intratumoral therapy, ImmunoPulse IL-12, with an immune checkpoint inhibitor is a promising approach for triple-negative breast cancer patients, a Phase 1 clinical trial suggests. The approach induced robust ... Read more

January 17, 2018

Syndax, Genentech to Test Combo Therapy for HR-positive, HER2-negative Metastatic Breast Cancer

News

An upcoming Phase 1b/2 trial will evaluate Syndax Pharmaceuticals‘ investigational therapy entinostat in combination with Genentech‘s Tecentriq (atezolizumab) in women with hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative ... Read more

January 15, 2018

FDA Approves Lynparza to Treat BRCA-mutated Metastatic Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Lynparza (olaparib) for a difficult-to-treat form of metastatic breast cancer. Patients with BRCA-mutated, HER2-negative breast cancer who have previously been treated ... Read more

January 12, 2018

Women Working Night Shift Show Increased Risk of Breast Cancer, Meta-analysis Suggests

News

Women who work the night shift have increased odds of developing breast, skin, and gastrointestinal cancer, a new meta-analysis shows. Nurses working night shifts seem to be at even higher ... Read more

January 10, 2018

Kisqali Granted Breakthrough Therapy Status to Treat Breast Cancer in Premenopausal Women

News

The U.S. Food and Drug Administration (FDA) has granted Kisqali (ribociclib) Breakthrough Therapy designation for the treatment of premenopausal women with HR-positive, HER2-negative advanced breast cancer who have not received prior endocrine ... Read more

January 8, 2018January 8, 2018

Processed Meat Consumption May Increase Post-Menopausal Breast Cancer Risk, Study Finds

News

Consumption of processed meat may increase the risk of breast cancer in post-menopausal women, a large-scale study by researchers at the University of Glasgow suggests. Researchers did not find a ... Read more

January 5, 2018

Biannual MRI Better Than Annual Mammogram at Detecting Breast Cancer in High-risk Women, Study Finds

News

For young women with high genetic risk for breast cancer, intensive surveillance and examination by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) every six months is more effective for timely detection of ... Read more

January 3, 2018

ESMO Urges Improved Supportive, Palliative Care for Cancer Patients

News

The European Society for Medical Oncology (ESMO) has released a new position paper on supportive and palliative care that advocates for integrating patient-centered care into overall anticancer treatment by a ... Read more

December 22, 2017December 22, 2017

Consuming Soy Foods, Cruciferous Vegetables May Reduce Treatment Side Effects, Study Finds

News

Consuming soy foods and cruciferous vegetables may reduce common side effects reported by breast cancer patients during and after treatment, a study found. In the study, researchers at Georgetown Lombardi Comprehensive ... Read more